Coronary heart disease mortality in treated familial hypercholesterolaemia:Update of the UK Simon Broome FH register

Background and aims: Patients with familial hypercholesterolaemia (FH) have an elevated risk of coronary heart disease (CHD). Here we compare changes in CHD mortality in patients with heterozygous (FH) pre 1992, before lipid-lowering therapy with statins was used routinely, and in the periods 1992–2008 and 2008–2016. Methods: 1903 Definite (DFH) and 1650 Possible (PFH) patients (51% women) aged 20–79 years, recruited from 21 lipid clinics in the United Kingdom and followed prospectively between 1980 and 2016 for 67,060 person-years. The CHD standardised mortality ratio (SMR) compared to the po... Mehr ...

Dokumenttyp: Artikel
Erscheinungsdatum: 2018
Reihe/Periodikum: The Simon Broome Familial Hyperlipidaemia Register Group 2018 , ' Coronary heart disease mortality in treated familial hypercholesterolaemia : Update of the UK Simon Broome FH register ' , Atherosclerosis , vol. 274 , pp. 41-46 . https://doi.org/10.1016/j.atherosclerosis.2018.04.040
Schlagwörter: Cancer mortality / Coronary mortality / Dutch lipid clinic network score / Heterozygous familial hypercholesterolemia
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26664813
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://research.manchester.ac.uk/en/publications/06c2479f-86f5-4ade-ac44-af53f9183a02